One study shows that HectH9 E3 ligase can play a key role in glucose metabolism regulation in prostate cancer via its control on the ubiquitination of hexokinase 2 (HK2), and the HectH9-HK2 pathway can regulate the maintenance of PC3-derived PCSCs [17]. This evidence concerns the gene HK2 and prostate carcinoma.